ARTL Stock Catalyst: Artelo Biosciences Announces Publication of Peer-Reviewed Article on FABPs in Cancer

Nov 3, 2025 · 4:43pm ET

The article was published on November 4, 2025.

Max move

+83.0%

High of day $148.23

Sparker timei

4:43pm ET

ARTL · Nov 3, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Artelo Biosciences, Inc. (Nasdaq: ARTL) announced on November 4, 2025, the publication of a peer-reviewed article detailing the role of Fatty Acid Binding Proteins (FABPs) in cancer. The article contributes to the understanding of FABPs' impact on cancer mechanisms.

The publication is part of Artelo Biosciences' ongoing research efforts in the biotechnology sector. The company's free float stands at 2,009,200 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time ARTL sparks.

Download Sniper App →

Catch the next ARTL-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →